Liver Fibrosis Serum Markers indicate Risk of Heart Failure

被引：0
|
作者：
Klein, Friederike
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2025年 / 63卷 / 01期
关键词：
D O I：
10.1055/a-2392-2175
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Liver disease is a risk factor for cardiovascular events. It is known, for example, that cardiovascular causes of death are the leading cause of steatotic liver disease associated with metabolic dysfunction (MASLD). Liver fibrosis is the final stage of various liver diseases and is also associated with cardiovascular diseases.
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Caution before embracing serum markers of liver fibrosis in clinical practice
    Park, G
    Katelaris, P
    Jones, DB
    Ngu, M
    Le Couteur, D
    GASTROENTEROLOGY, 2005, 128 (04) : 1145 - 1146
  • [42] Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities
    Guha, In
    Rosenberg, W. M.
    CLINICS IN LIVER DISEASE, 2008, 12 (04) : 883 - +
  • [43] Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
    Chen, Qingling
    Mei, Ling
    Zhong, Rui
    Han, Ping
    Wen, Jun
    Han, Xu
    Zhai, Lu
    Zhao, Lili
    Li, Jia
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [44] Gender differences in electrocardiographic risk markers of heart failure
    Haukilahti, M. A. E.
    Kentta, T. V.
    Tikkanen, J.
    Anttonen, O.
    Aro, A.
    Kerola, T.
    Rissanen, H.
    Knekt, P.
    Junttila, M. J.
    Huikuri, H. V.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2121 - 2121
  • [45] Heart failure after myocardial revascularization: Risk markers
    Biffi, M
    Bertini, M
    Boriani, G
    Martignani, C
    Branzi, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 105 (01) : 11 - 14
  • [46] Serum apoptosis markers in acute liver failure: A pilot study
    Rutherford, Anna E.
    Hynan, Linda S.
    Borges, Carolina B. S.
    Forcione, David G.
    Blackard, Jason T.
    Lin, Wenyu
    Gorman, April R.
    Shaikh, Obaid Shakil
    Reuben, Adrian
    Harrison, Edwyn
    Reddy, K. Rajender
    Le, William M.
    Chung, Raymond T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (12) : 1477 - 1483
  • [47] Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers
    Danan Wang
    Qinghui Wang
    Fengping Shan
    Beixing Liu
    Changlong Lu
    BMC Infectious Diseases, 10
  • [48] Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers
    Wang, Danan
    Wang, Qinghui
    Shan, Fengping
    Liu, Beixing
    Lu, Changlong
    BMC INFECTIOUS DISEASES, 2010, 10
  • [49] Is Fatty Liver a Risk Marker for Heart Failure?
    VanWagner, Lisa B.
    OBESITY, 2017, 25 (08) : 1302 - 1302
  • [50] The relationship between serum fibrosis markers and fibrosis in liver tissue in patients with chronic viral hepatitis
    Candevir, A.
    Aksu, H. S. Z.
    Kurtaran, B.
    Inal, A. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S336 - S336
12345